Steris (NYSE:STE) updated its FY20 earnings guidance on Monday. The company provided earnings per share guidance of $5.38-5.53 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.40. Steris also updated its FY 2020 guidance to $5.38-5.53 EPS.
A number of research analysts have recently commented on STE shares. Zacks Investment Research raised Steris from a hold rating to a buy rating and set a $146.00 price target on the stock in a report on Tuesday, April 30th. JMP Securities raised their price target on Steris from $135.00 to $150.00 and gave the company a market outperform rating in a report on Wednesday, May 22nd. KeyCorp raised their price target on Steris from $135.00 to $138.00 and gave the company an overweight rating in a report on Wednesday, May 15th. Finally, Stephens raised their price target on Steris from $135.00 to $150.00 and gave the company an overweight rating in a report on Wednesday, May 15th. Five analysts have rated the stock with a buy rating, The stock currently has a consensus rating of Buy and an average price target of $148.20.
Shares of STE traded down $1.84 during trading hours on Wednesday, reaching $150.48. 15,887 shares of the company’s stock traded hands, compared to its average volume of 424,870. The company has a market cap of $12.88 billion, a price-to-earnings ratio of 30.65 and a beta of 0.98. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.27 and a quick ratio of 1.82. Steris has a twelve month low of $99.14 and a twelve month high of $154.09. The stock has a fifty day simple moving average of $148.38.
The company also recently announced a quarterly dividend, which will be paid on Thursday, September 26th. Investors of record on Tuesday, September 10th will be issued a dividend of $0.37 per share. This is a positive change from Steris’s previous quarterly dividend of $0.34. This represents a $1.48 dividend on an annualized basis and a yield of 0.98%. The ex-dividend date of this dividend is Monday, September 9th. Steris’s payout ratio is presently 27.81%.
In related news, insider Michael J. Tokich sold 22,000 shares of Steris stock in a transaction dated Friday, June 21st. The stock was sold at an average price of $143.70, for a total transaction of $3,161,400.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Kathleen Bardwell sold 7,000 shares of Steris stock in a transaction dated Friday, June 28th. The stock was sold at an average price of $147.07, for a total value of $1,029,490.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 244,145 shares of company stock worth $33,121,338. 2.36% of the stock is owned by corporate insiders.
Steris Company Profile
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Featured Story: Is the Dow Jones Industrial Average (DJIA) still relevant?
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.